These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 35383784)

  • 1. Network pharmacology combined with metabolomics and lipidomics to reveal the hypolipidemic mechanism of
    Yan P; Wei Y; Wang M; Tao J; Ouyang H; Du Z; Li S; Jiang H
    Food Funct; 2022 Apr; 13(8):4714-4733. PubMed ID: 35383784
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on mechanism of hepatoprotective effect of Chrysanthemum morifolium Ramat. based on metabolomics with network analysis and network pharmacology.
    Yang M; Sun S; Jia X; Wen X; Tian X; Niu Y; Wei J; Jin Y; Du Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1222():123711. PubMed ID: 37059010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabonomics coupled with HPLC-LTQ/orbitrap MS and multivariate data analysis on the ameliorative effects of Bidens bipinnata L. in hyperlipidemic rats.
    Wang YQ; Li SJ; Man YH; Zhuang G
    J Ethnopharmacol; 2020 Nov; 262():113196. PubMed ID: 32730873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.
    Zhong Y; Xu Y; Tan Y; Zhang X; Wang R; Chen D; Wang Z; Zhong X
    J Pharm Biomed Anal; 2023 Jun; 230():115386. PubMed ID: 37044004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia.
    Zeng B; Qi L; Wu S; Liu N; Wang J; Nie K; Xia L; Yu S
    J Vis Exp; 2023 Apr; (194):. PubMed ID: 37092814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet.
    Dan H; Wu J; Peng M; Hu X; Song C; Zhou Z; Yu S; Fang N
    Saudi Med J; 2011 Jul; 32(7):701-7. PubMed ID: 21748207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Mechanism of
    Ge PY; Qi YY; Qu SY; Zhao X; Ni SJ; Yao ZY; Guo R; Yang NY; Zhang QC; Zhu HX
    Drug Des Devel Ther; 2021; 15():1915-1930. PubMed ID: 33976541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia.
    Miao H; Zhang L; Chen DQ; Chen H; Zhao YY; Ma SC
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27571931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology strategy through integrating metabolomics and network pharmacology to reveal the mechanisms of Xiaopi Hewei Capsule improves functional dyspepsia.
    Liu R; Li T; Xu H; Yu G; Zhang T; Wang J; Sun Y; Bi Y; Feng X; Wu H; Zhang C; Sun Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1226():123676. PubMed ID: 37329776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice.
    Li S; Jin S; Song C; Chen C; Zhang Y; Xiang Y; Xu Y; Feng Y; Wan Q; Jiang H
    J Ethnopharmacol; 2016 Jan; 177():10-8. PubMed ID: 26584875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-colorectal cancer mechanism of Astragali Radix-Curcumae Rhizoma-Paridis Rhizoma based on network pharmacology and experimental verification].
    Liang Y; Sun RL; Liu FY; Liu TT; Guan HQ; Tang DC
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):776-785. PubMed ID: 35178961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fagopyrum Dibotrys Rhizoma regulates pulmonary lipid metabolic homeostasis and the ERK-cPLA
    Wang X; Zhao B; Ruan Y; Xu W; Luo Z; Xu J; Shi C; Shan J
    Phytomedicine; 2024 Aug; 131():155782. PubMed ID: 38851102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl
    Ma L; Chen Y; Yue R; Li Z; Wang Y; Bian Y; Wang M
    J Proteomics; 2024 Jul; 304():105227. PubMed ID: 38878880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated metabolomics and network pharmacology to reveal the lipid-lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats.
    Zhao L; Wang S; Xu X; Guo W; Yang J; Liu Y; Xie S; Piao G; Xu T; Wang Y; Xu Y
    J Sci Food Agric; 2024 Apr; 104(6):3265-3274. PubMed ID: 38087399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated lipidomics and network pharmacology analysis of the protective effects and mechanism of Yuanzhi San on rats with cognitive impairment.
    Wang J; Li J; Liu K; Wang S; Su Q; Cheng Y; Wang Y; Wang Y
    Bioorg Med Chem; 2022 Mar; 58():116651. PubMed ID: 35176586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Lipidomics and Network Pharmacology Reveal Mechanism of Memory Impairment Improvement by Yuanzhi San.
    Zhao F; Li P; Deng F; Wang J; Cheng Y; Pei K; Wang Y; Wang Y
    Chem Biodivers; 2023 Mar; 20(3):e202200920. PubMed ID: 36683009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the mechanisms underlying the anti-hyperlipidemic effects of Laportea bulbifera using integrated serum metabolomics and network pharmacology.
    Shi Q; Lin Y; Huang L; Jin S; Huang R; Zhang L; Song C; Xu L; Zhang S
    Biomed Chromatogr; 2023 Oct; 37(10):e5707. PubMed ID: 37496197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway.
    Lan T; Li Q; Chang M; Yin C; Zhu D; Wu Z; Li X; Zhang W; Yue B; Shi J; Yuan H; Su Z; Guo H
    J Ethnopharmacol; 2020 Oct; 260():112989. PubMed ID: 32526339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining bioinformatics and multiomics strategies to investigate the key microbiota and active components of Liupao tea ameliorating hyperlipidemia.
    Zhou H; Wang X; She Z; Huang L; Wei H; Yang S; Wei Z; Chen H; Yang B; Hu Z; Feng X; Zhu P; Li Z; Shen J; Liu H; Dong H; Chen G; Zhang Q
    J Ethnopharmacol; 2024 Oct; 333():118438. PubMed ID: 38848972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.